Skip to main content
. Author manuscript; available in PMC: 2023 Jan 27.
Published in final edited form as: Nanoscale. 2022 Jan 27;14(4):1054–1074. doi: 10.1039/d1nr03831a

Fig. 2.

Fig. 2

Models of protein nanoparticle-based SARS-CoV-2 vaccines. (a) 2D diagram of a receptor-binding domain (RBD)-coated protein nanoparticle vaccine. The RBD (green) is captured by the nanoparticle (gray) through the interactions between the SpyTag (orange) on the RBD and SpyCatcher (blue) on the nanoparticle. (b) 3D models of the nanoparticle coated by 60 copies of SARS-CoV-2 RBD or 20 copies of SARS-CoV-2 spike (S) trimer.